FeeBase
Log inGet started
Menu
On this page

CMS RVU26D · Effective 2026-10-01

96417 Chemotherapy infusion Medicare reimbursement rates in Virginia

Reports an additional sequential intravenous infusion of a different chemotherapy drug or substance, following a primary chemotherapy infusion service. Compare 96417 office and facility rates across CMS payment localities in Virginia.

Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.

What does Medicare pay for 96417 in Virginia?

Virginia has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.

Office / nonfacility

$65.18–$77.36

2 of 2 localities have a supported rate.

Lowest: Virginia

Highest: Dc + Md/Va Suburbs

A spread of $12.18 per service.

Facility setting

No supported rate

These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.

Find 96417 in your payment locality →

Chemotherapy administration

About 96417: Sequential intravenous chemotherapy infusion

Reports an additional sequential intravenous infusion of a different chemotherapy drug or substance, following a primary chemotherapy infusion service.

This code represents an additional sequential intravenous infusion of a different chemotherapy drug or substance, generally administered by clinical staff in an oncology office or infusion setting. The next drug is given in sequence rather than concurrently with the preceding infusion. It is distinct from extra time spent continuing the same drug and from chemotherapy delivered by injection or prolonged pump infusion.

Report it as an add-on with the primary chemotherapy administration service when documentation supports a separate sequential infusion of another drug. The medication administration record and infusion documentation should identify the drugs and show their sequence and administration times. For Medicare, this add-on is paid within the primary procedure's global period. CMS classifies it as an incident-to service, so it is billed only when performed under physician supervision.

CMS billing rules for 96417

Global period
Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
Professional and technical components
Incident-to service: billed only when performed under physician supervision.

Where the value comes from

  • Work RVU0.21 · 11%
  • Practice expense (office) RVU1.75 · 88%
  • Malpractice RVU0.03 · 2%

323.3K

Medicare services in 2024 · #295 by national volume

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

96417 compared with similar codes

Office rates for Virginia, from the same CMS release.

96413

Chemo IV infusion

Initial drug, first hour

$130.52–$155.68

96413 reports the primary intravenous chemotherapy infusion. Use 96417 for an additional different drug infused sequentially after that primary service.

96415

Chemo infusion add-on

Each additional hour

$27.83–$32.61

96415 reports additional time when an infusion continues; 96417 represents a separate sequential infusion of a different drug or substance.

96411

IV chemotherapy push

Each additional drug

$55.98–$66.39

96411 is for an additional chemotherapy drug administered by intravenous push. 96417 is for a different drug given as a sequential infusion.

96416

Pump infusion

Prolonged infusion over eight hours

$130.48–$155.97

96416 describes prolonged chemotherapy infusion using a pump. 96417 identifies an additional sequential infusion of a different drug.

Compare 96417 by payment locality

Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.

2 of 2 payment localities

Office and facility base rates · shared scale starting at $0

Need rates for a whole code list?

Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.

Explore fee-sheet early access →

96417 billing questions

When is 96417 reported with 96413?

Report 96417 for an additional sequential infusion of a different chemotherapy drug after the primary infusion service. It is an add-on and cannot stand alone.

Is 96417 for extra time with the same drug?

No. It represents a sequential infusion of a different drug or substance; 96415 is used for additional infusion time when the same infusion continues.

Can 96417 describe a concurrent infusion?

No. The additional drug must be infused sequentially, not concurrently with the preceding infusion.

What documentation supports a unit of 96417?

Document the additional drug, its sequential administration, and the infusion times in the medication administration and infusion records. The service represents an additional sequential infusion, not another hour of the same infusion.

What supervision is required for Medicare billing?

CMS classifies 96417 as an incident-to service. It is billed only when performed under physician supervision.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.

Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.

RVUs for 96417PPRRVU2026_Oct_nonQPP.csv, line 12,804 (RVU26D)
Open CMS sourceHow this rate is calculatedBuild a fee sheet